We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$5.65B
AUM Growth
+$471M
Cap. Flow
+$283M
Cap. Flow %
5.01%
Top 10 Hldgs %
17.56%
Holding
1,507
New
476
Increased
192
Reduced
202
Closed
448

Top Sells

Rank Stock Value
1
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$16.7M
2
SABR icon
Sabre
SABR
+$12.5M
3
UBS icon
UBS Group
UBS
+$10.2M
4
DIS icon
Walt Disney
DIS
+$9.97M
5
CBL
CBL Properties
CBL
+$7.85M

Sector Composition

Rank Sector Weight
1 Healthcare 2.56%
2 Technology 1.89%
3 Consumer Discretionary 0.9%
4 Communication Services 0.87%
5 Industrials 0.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPEN icon
1051
Opendoor
OPEN
$3.64B
$2.81K ﹤0.01%
723
OPEN icon
1052
PUT
Opendoor
OPEN
$3.64B
$2.81K ﹤0.01%
723
AZN icon
1053
AstraZeneca
AZN
$263B
$1.5K ﹤0.01%
11
-13,489
-100% -$1.98M
JNJ icon
1054
Johnson & Johnson
JNJ
$618B
$1.32K ﹤0.01%
8
-7,992
-100% -$1.29M
OZON
1055
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$928 ﹤0.01%
80
VAL.WS icon
1056
Valaris Ltd Warrants
VAL.WS
$684M
$696 ﹤0.01%
66
ML.WS
1057
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$585 ﹤0.01%
15,476
MIMO.WS
1058
DELISTED
Airspan Networks Holdings Inc Warrants
MIMO.WS
$249 ﹤0.01%
207,222
BBBY
1059
DELISTED
Bed Bath & Beyond Inc
BBBY
$160 ﹤0.01%
583
AAL icon
1060
American Airlines Group
AAL
$10.1B
-87,315
Closed -$1.28M
ABEV icon
1061
PUT
Ambev
ABEV
$48.1B
-1,490,000
Closed -$4.2M
ABG icon
1062
Asbury Automotive
ABG
$4.31B
-5,000
Closed -$1.05M
ABG icon
1063
PUT
Asbury Automotive
ABG
$4.31B
-10,000
Closed -$2.1M
ACHC icon
1064
CALL
Acadia Healthcare
ACHC
$2.76B
-25,000
Closed -$1.81M
ACI icon
1065
CALL
Albertsons Companies
ACI
$5.62B
-200,000
Closed -$4.16M
ACLX
1066
CALL
DELISTED
Arcellx
ACLX
-12,500
Closed -$385K
ACLX
1067
PUT
DELISTED
Arcellx
ACLX
-12,500
Closed -$385K
ACRS icon
1068
PUT
Aclaris Therapeutics
ACRS
$726M
-625,000
Closed -$5.06M
AGIO icon
1069
Agios Pharmaceuticals
AGIO
$1.79B
-4,086
Closed -$102K
AI icon
1070
C3.ai
AI
$1.43B
-33,300
Closed -$938K
ALC icon
1071
CALL
Alcon
ALC
$33.6B
-10,000
Closed -$705K
ALKS icon
1072
CALL
Alkermes
ALKS
$8.22B
-750,000
Closed -$21.1M
ALLO icon
1073
Allogene Therapeutics
ALLO
$649M
-74,900
Closed -$370K
ALLO icon
1074
PUT
Allogene Therapeutics
ALLO
$649M
-153,400
Closed -$758K
ALLY icon
1075
PUT
Ally Financial
ALLY
$13.2B
-311,700
Closed -$7.95M

Similar funds

Caption Management's Q2 2023 Portfolio in Review

As of Q2 2023, Caption Management held 1,507 positions worth $5.65B, up 9.1% from $5.18B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management deployed $283M of net new capital in Q2 2023, opening 476 new positions and adding to 192 existing holdings. Its largest new stake was Lockheed Martin: 31,000 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 2% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Sabre, an estimated $12.5M trimmed.

  • Caption Management's largest Q2 2023 buy was Lockheed Martin: 31,000 shares worth $14.3M.
  • Caption Management added most to State Street SPDR S&P Biotech ETF in Q2 2023, an estimated $11M increase.
  • Caption Management's biggest Q2 2023 reduction was Sabre, cutting an estimated $12.5M.
  • Caption Management fully exited KraneShares CSI China Internet ETF in Q2 2023, selling an estimated $16.7M.
  • Caption Management's ten largest holdings make up 18% of its $5.65B portfolio in Q2 2023.
  • Caption Management opened 476 new positions and closed 448 in Q2 2023.
  • Caption Management's portfolio value rose 9.1% quarter-over-quarter to $5.65B.

Based on Caption Management's 13F filing for Q2 2023, filed 14 Aug 2023.